Patients with multiple trauma with thoracic trauma have higher death rates compared to multiple trauma patients without thoracic trauma, mainly because of cardiac injury. We investigated the 24 hours prognostic value of NT-proB-type Natriuretic Peptide (Nt-ProBNP) in polytraumatised patients with thoracic trauma.
The study group was composed of 33 patients, 25 males and 8 females. During the study, the endpoint, which was death in the first 24 hours after admission was observed in 33% of the patients (11 patients).
Using a cut-off point of 125 pg/ml, the sensitivity of the test was 100% and the specificity was 59.09%.
Accoring to the results of the study, NT-ProBNP proves that it might be useful in detecting patients with a bad prognosis, the analyzed enzyme having the capacity of identifying polytrauma patients with thoracic trauma that have high risk of death in the first 24 hours after admission.
1. Pape HC, Peitzman AB, Schwab CW, Giannoudis PV. Damage Control Management in the Polytrauma Patient: Springer New York; 2010.
2. Masella CA, Pinho VF, Costa Passos AD, Spencer Netto FA, Rizoli S, Scarpelini S. Temporal distribution of trauma deaths: quality of trauma care in a developing country. J Trauma. 2008;65(3):653-8.
3. Chrysou K, Halat G, Hoksch B, Schmid RA, Kocher GJ. Lessons from a large trauma center: impact of blunt chest trauma in polytrauma patients—still a relevant problem? Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. 2017;25:42.
4. Vécsei V, Arbes S, Aldrian S, Nau T. Chest Injuries in Polytrauma. European Journal of Trauma. 2005;31(3):239-43.
5. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527.
6. Schisler JC, Lang CH, Willis M. Endocrinology of the Heart in Health and Disease: Integrated, Cellular, and Molecular Endocrinology of the Heart: Elsevier Science; 2016.
7. Kirchhoff C, Leidel BA, Kirchhoff S, Braunstein V, Bogner V, Kreimeier U, et al. Analysis of N-terminal pro-B-type natriuretic peptide and cardiac index in multiple injured patients: a prospective cohort study. Critical Care. 2008;12(5):R118-R.
8. Dogan H, Sarikaya S, Neijmann ST, Uysal E, Yucel N, Ozucelik DN, et al. N-terminal pro-B-type natriuretic peptide as a marker of blunt cardiac contusion in trauma. International journal of clinical and experimental pathology. 2015;8(6):6786-92.
9. Lee CY, Bae MK, Lee JG, Kim K-W, Park IK, Chung KY. N-Terminal Pro-B-type Natriuretic Peptide Is Useful to Predict Cardiac Complications Following Lung Resection Surgery. The Korean Journal of Thoracic and Cardiovascular Surgery. 2011;44(1):44-50.
10. Salvatici M, Cardinale D, Spaggiari L, Veglia F, Tedesco CC, Solli P, et al. Atrial fibrillation after thoracic surgery for lung cancer: use of a single cut-off value of N-terminal pro-B type natriuretic peptide to identify patients at risk. Biomarkers. 2010;15(3):259-65.
11. Cardinale D, Colombo A, Sandri MT, Lamantia G, Colombo N, Civelli M, et al. Increased perioperative N-terminal pro-Btype natriuretic peptide levels predict atrial fibrillation after thoracic surgery for lung cancer. Circulation. 2007;115(11):1339-44.
12. Kristensen SL, Jhund PS, Mogensen UM, Rorth R, Abraham WT, Desai A, et al. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation. Circulation Heart failure. 2017;10(10).
13. Feringa HH, Bax JJ, Elhendy A, de Jonge R, Lindemans J, Schouten O, et al. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass. The American journal of cardiology. 2006;98(1):111-5.